63.8 F
Fort Worth
Monday, September 28, 2020
- Advertisements -
Health Care Fort Worth biotech startup helping increase COVID-19 testing capabilities

Fort Worth biotech startup helping increase COVID-19 testing capabilities

Other News

Wall Street posts solid gains after surge in corporate deals

By ALEX VEIGA and DAMIAN J. TROISE AP Business Writers Wall Street kicked off the week with a broad...

Tarrant County ranks low in work-from-home study by NAR

North Texas ranks pretty high in the “Work from Home” category, according to a just-released study by the National Association of Realtors....

Commentary: Universities and COVID-19: Charting turbulent times

Ray Perryman As the COVID-19 pandemic emerged this spring, college campuses across the United States swiftly sent students...

Linear Labs introduces electric motor that will fit inside a pocket

Leading the new wave of electrification, a Fort Worth-based technology company has built an electric motor that can fit inside one's pocket,...

As concerns mount over lack of coronavirus testing in the U.S., a Fort Worth-based biotech startup has stepped up to speed the process.

Exact Diagnostics has launched a SARS CoV-2 Standard to support laboratory assay validation of coronavirus testing, the company announced.

The company, which currently operates out of the University of North Texas Health Science Center, is offering the first 200 standards (one per account) of SARS CoV-2 Standard free of charge to labs across the U.S.

The SARS CoV-2 Standard should help labs keep pace with the increasing demand for testing.

Federal regulations require clinical laboratories to establish and document their performance specifications for laboratory-developed tests to ensure accurate and precise results before human implementations take place.

Exact Diagnostics’ SARS CoV-2 Standard contains synthetic RNA transcripts that have three gene targets – E, N and S Genes of SARS-CoV-2. It also launched the SARS-CoV-2 Negative, negative for SARS-CoV-2 that has a formulated synthetic matrix and contains human genomic DNA.

The product launches will help labs validate the entire process of a molecular assay including extraction, amplification, and detection.

California-based life science giant Bio-Rad Laboratories had acquired the Fort Worth startup in August.

“In a public health emergency, it is critical that labs have access to well-defined standards to help with the validation of their tests,” Dara Wright, Bio-Rad executive vice president, said in a statement. “The SARS CoV-2 Standard helps to validate COVID-19 tests, which enables more laboratories to meet the growing demand for identification of this coronavirus.”

According to Centers for Disease Control and Prevention [CDC], 84 state and local public health laboratories in 50 states and the District of Columbia have successfully verified COVID-19 diagnostic tests and are offering testing.

After have low number of tests available in the first two months of the year, testing in U.S. labs for COVID-19 has drastically risen in the last couple of weeks.

- Advertisements -
- Advertisements -

Latest News

How a glitchy computer system skewed Texas’ coronavirus data and hampered its pandemic response

By Shannon Najmabadi and Edgar Walters, The Texas Tribune Sept. 24, 2020 "How a...

2 COVID deaths reported Friday in Tarrant County

Tarrant County Public Health reported two COVID-19 deaths on Friday Setp. 25. The deceased include a man from Arlington in his 80s,...

After Ginsburg’s death, high stakes for Texas’ legal challenge to the Affordable Care Act

By Emma Platoff and Edgar Walters, The Texas Tribune Sept. 25, 2020 "After Ginsburg’s...

New measurements show moon has hazardous radiation levels

By MARCIA DUNN AP Aerospace Writer CAPE CANAVERAL, Fla. (AP) — Future moon explorers will be bombarded with two...

Houston sampling wastewater to track spread of COVID-19

By JUAN A. LOZANO Associated PressHOUSTON (AP) — Results from a program that's testing Houston's wastewater to monitor the local spread of...